The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
Authors
Keywords
-
Journal
HEADACHE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-12-10
DOI
10.1111/head.13456
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)
- (2018) Amaal J Starling et al. CEPHALALGIA
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Non-Pharmacological Approaches for Migraine
- (2018) Francesca Puledda et al. Neurotherapeutics
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention
- (2018) Vladimir Skljarevski et al. JAMA Neurology
- The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine
- (2017) Bianca Raffaelli et al. EXPERT OPINION ON PHARMACOTHERAPY
- Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary
- (2017) Ariane K. Kawata et al. HEADACHE
- Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines
- (2017) Joshua M. Cohen et al. HEADACHE
- A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine
- (2017) Sagar Munjal et al. JOURNAL OF HEADACHE AND PAIN
- Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine
- (2017) Roger K. Cady et al. JOURNAL OF HEADACHE AND PAIN
- Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design
- (2017) Daniel Serrano et al. JOURNAL OF HEADACHE AND PAIN
- National Trends in Direct Health Care Expenditures Among US Adults With Migraine: 2004 to 2013
- (2017) Amit D. Raval et al. JOURNAL OF PAIN
- Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2017) Valery L Feigin et al. LANCET NEUROLOGY
- External Trigeminal Nerve Stimulation for the Acute Treatment of Migraine: Open-Label Trial on Safety and Efficacy
- (2017) Denise E. Chou et al. NEUROMODULATION
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Premonitory symptoms in migraine: A cross-sectional study in 2714 persons
- (2016) Katarina Laurell et al. CEPHALALGIA
- A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults
- (2016) Sagar Munjal et al. HEADACHE
- Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches
- (2016) Sally Mannix et al. Health and Quality of Life Outcomes
- Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Hong Sun et al. LANCET NEUROLOGY
- Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache
- (2016) David M. Simpson et al. NEUROLOGY
- Drug safety in acute migraine treatment
- (2015) János Tajti et al. Expert Opinion On Drug Safety
- AVP-825 Breath-Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks
- (2015) Stewart J. Tepper et al. HEADACHE
- The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies
- (2015) Michael J. Marmura et al. HEADACHE
- A pilot study of cognitive behavioural therapy and relaxation for migraine headache: a randomised controlled trial
- (2015) S. Cousins et al. JOURNAL OF NEUROLOGY
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
- (2015) Marcelo E Bigal et al. LANCET NEUROLOGY
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
- (2015) Marcelo E Bigal et al. LANCET NEUROLOGY
- Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine
- (2015) R. B. Lipton et al. NEUROLOGY
- Adherence to oral migraine-preventive medications among patients with chronic migraine
- (2014) Zsolt Hepp et al. CEPHALALGIA
- A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)
- (2014) Roger K. Cady et al. HEADACHE
- Revised French guidelines for the diagnosis and management of migraine in adults and children
- (2014) Michel Lanteri-Minet et al. JOURNAL OF HEADACHE AND PAIN
- Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
- (2014) David W Dodick et al. LANCET NEUROLOGY
- What Do Patients Consider to Be the Most Important Outcomes for Effectiveness Studies on Migraine Treatment? Results of a Delphi Study
- (2014) Antonia F. H. Smelt et al. PLoS One
- Cutaneous allodynia as a predictor of migraine chronification
- (2013) Mark A. Louter et al. BRAIN
- Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)
- (2013) Andrew M. Blumenfeld et al. HEADACHE
- Cost and Predictors of Lost Productive Time in Chronic Migraine and Episodic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study
- (2013) Daniel Serrano et al. VALUE IN HEALTH
- Cutaneous allodynia in patients with episodic migraine
- (2012) Hayat Güven et al. NEUROLOGICAL SCIENCES
- Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Table 1
- (2012) S.D. Silberstein et al. NEUROLOGY
- Validating Migraine-Specific Quality of Life Questionnaire v2.1 in Episodic and Chronic Migraine
- (2011) Christine L. Bagley et al. HEADACHE
- Headache Impact of Chronic and Episodic Migraine: Results From the American Migraine Prevalence and Prevention Study
- (2011) Dawn Buse et al. HEADACHE
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
- (2010) SK Aurora et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
- (2010) HC Diener et al. CEPHALALGIA
- Biofeedback in headache: An overview of approaches and evidence
- (2010) F. ANDRASIK CLEVELAND CLINIC JOURNAL OF MEDICINE
- Validity and Reliability of the Migraine-Treatment Optimization Questionnaire
- (2009) RB Lipton et al. CEPHALALGIA
- A Comparison of Migraine Patients With and Without Allodynic Symptoms
- (2009) Jayantee Kalita et al. CLINICAL JOURNAL OF PAIN
- Medication overuse headache
- (2009) Zaza Katsarava et al. Current Neurology and Neuroscience Reports
- EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force
- (2009) S. Evers et al. EUROPEAN JOURNAL OF NEUROLOGY
- Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study
- (2009) Julie Munakata et al. HEADACHE
- Guidelines for Controlled Trials of Prophylactic Treatment of Chronic Migraine in Adults
- (2008) S Silberstein et al. CEPHALALGIA
- Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population-Based Study
- (2008) Marcelo E. Bigal et al. HEADACHE
- Cutaneous allodynia in the migraine population
- (2007) Richard B. Lipton et al. ANNALS OF NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now